These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6597458)

  • 1. Phenylethylamine excretion in depression.
    DeLisi LE; Murphy DL; Karoum F; Mueller E; Targum S; Wyatt RJ
    Psychiatry Res; 1984 Nov; 13(3):193-201. PubMed ID: 6597458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluctuating high urinary phenylethylamine excretion rates in some bipolar affective disorder patients.
    Karoum F; Linnoila M; Potter WZ; Chuang LW; Goodwin FK; Wyatt RJ
    Psychiatry Res; 1982 Apr; 6(2):215-22. PubMed ID: 6953460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements.
    Sabelli HC; Fawcett J; Gusovsky F; Javaid JI; Wynn P; Edwards J; Jeffriess H; Kravitz H
    J Clin Psychiatry; 1986 Feb; 47(2):66-70. PubMed ID: 3944066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary phenylethylamine correlates positively with hypomania, and negatively with depression, paranoia, and social introversion on the MMPI.
    Moises HW; Waldmeier P; Beckmann H
    Eur Arch Psychiatry Neurol Sci; 1986; 236(2):83-7. PubMed ID: 3792411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man.
    Karoum F; Potkin S; Chuang LW; Murphy DL; Liebowitz MR; Wyatt RJ
    Biol Psychiatry; 1984 Feb; 19(2):165-78. PubMed ID: 6713036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary phenylacetic acid excretion in depressive patients.
    González-Sastre F; Mora J; Guillamat R; Queraltó JM; Alvarez E; Udina C; Massana J
    Acta Psychiatr Scand; 1988 Aug; 78(2):208-10. PubMed ID: 3223321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylethylaminergic mechanisms in attention-deficit disorder.
    Baker GB; Bornstein RA; Rouget AC; Ashton SE; van Muyden JC; Coutts RT
    Biol Psychiatry; 1991 Jan; 29(1):15-22. PubMed ID: 2001444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary trace amine excretion and platelet monoamine oxidase activity in schizophrenia.
    Yoshimoto S; Kaku H; Shimogawa S; Watanabe A; Nakagawara M; Takahashi R
    Psychiatry Res; 1987 Jul; 21(3):229-36. PubMed ID: 3628609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary phenyl acetate: a diagnostic test for depression?
    Sabelli HC; Fawcett J; Gusovsky F; Javaid J; Edwards J; Jeffriess H
    Science; 1983 Jun; 220(4602):1187-8. PubMed ID: 6857245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylethylamine (PEA) and phenylacetic acid (PAA) in the urine of chronic schizophrenic patients and controls.
    Potkin SG; Wyatt RJ; Karoum F
    Psychopharmacol Bull; 1980 Jan; 16(1):52-4. PubMed ID: 7360842
    [No Abstract]   [Full Text] [Related]  

  • 11. Increase in urinary beta-phenylethylamine preceding the switch from mania to depression: a "rapid cycler".
    Semba J; Nankai M; Maruyama Y; Kaneno S; Watanabe A; Takahashi R
    J Nerv Ment Dis; 1988 Feb; 176(2):116-9. PubMed ID: 3339341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary phenylacetic acid in panic disorder with and without depression.
    Sabelli HC; Javaid JI; Fawcett J; Kravitz HM; Wynn P
    Acta Psychiatr Scand; 1990 Jul; 82(1):14-6. PubMed ID: 2399814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Platelet serotonin in endogenous depressive patients and normal controls].
    Spatz H; Spatz N
    Acta Psiquiatr Psicol Am Lat; 1995 Sep; 41(3):230-6. PubMed ID: 8728799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary phenethylamine response to d-amphetamine in 12 boys with attention deficit disorder.
    Zametkin AJ; Brown GL; Karoum F; Rapoport JL; Langer DH; Chuang LW; Wyatt RJ
    Am J Psychiatry; 1984 Sep; 141(9):1055-8. PubMed ID: 6380319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary phenylacetate and response to methylphenidate.
    Baxter LR; Kelly RC; Peter JB; Liston EH; Touserkani S
    J Psychiatr Res; 1988; 22(2):131-9. PubMed ID: 3404481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study on the acute effect of amphetamine on the urinary excretion of biogenic amines and metabolites in monkeys.
    Chuang LW; Karoum F; Perlow MJ
    Br J Pharmacol; 1981 Nov; 74(3):571-7. PubMed ID: 7296162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of urinary monoamine and metabolite output measurements in depressed patients.
    Linnoila M; Karoum F; Miller T; Potter WZ
    Am J Psychiatry; 1983 Aug; 140(8):1055-7. PubMed ID: 6191580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary phenylethylamine and cortisol levels in the early puerperium.
    Taylor A; Doré C; Glover V
    J Affect Disord; 1996 Apr; 37(2-3):137-42. PubMed ID: 8731076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls.
    Beckmann H; Reynolds GP; Sandler M; Waldmeier P; Lauber J; Riederer P; Gattaz WF
    Arch Psychiatr Nervenkr (1970); 1983; 232(6):463-71. PubMed ID: 6134517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression during methadone withdrawal: no role for beta-phenylethylamine.
    Kaufmann CA; Kreek MJ; Karoum F; Chuang LW
    Drug Alcohol Depend; 1984 Jan; 13(1):21-9. PubMed ID: 6734421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.